ReviewChemical science2025
Enabling technology for accelerated discovery of supramolecular materials.
Review in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoarchitectonics of molecular machines, biomolecular machines, and microrobots in their collective behaviour.Chemical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organic supramolecular materials, defined by their discrete, modular nature, promise to deliver flexible solutions to pressing challenges, including separations, storage, sensing, and catalysis. The absence of strong metallic or covalent bonding within their solid-state structures enables fine-tuning and post-synthetic processing to tailor properties towards specific applications. However, their production suffers from poor reproducibility, scalability, and sustainability; as a result, translation of these materials from the lab to real-world situations is rare. In this perspective, we discuss how the field stands to benefit from the emergence of 'enabling technologies', such as high-throughput screening (HTS), automation, and flow chemistry. We summarise recent advances and consider the opportunities these technologies present for the accelerated discovery, optimisation, and translation of supramolecular materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.